Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (51-60 of 414) with videos related to

Pageof 42
Sort By:
La Revue De Medecine Interne|May 1, 1990
[Anti-aggregants in 1990]M Verstraete
Acta Clinica Belgica|January 1, 1983
Thromboembolism in cancer patientsM Verstraete
La Revue Du Praticien|February 1, 1981
[Platelet antiaggregating agents]M Verstraete
Przeglad Lekarski|January 1, 1978
Antiplatelet agents in coronary disease: are they of prophylactic value?M Verstraete
Acta Clinica Belgica|January 1, 1981
The clinical relevance of hyperviscosityM Verstraete
Angiologica|January 1, 1970
Pseudo-intermittent claudicationM Verstraete
British Medical Journal|December 11, 1971
Streptokinase and myocardial infarctionM Verstraete
Panminerva Medica|April 1, 1973
The problem of new drugs in Europe. IntroductionM Verstraete
Drugs|January 1, 1991
Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseasesM Verstraete
British Journal of Clinical Pharmacology|January 1, 1983
Introduction: thromboxane in biological systems and the possible impact of its inhibitionM Verstraete
Pageof 42

Showing results (51-60 of 414) with videos related to

Sort By:
Pageof 42
La Revue De Medecine Interne|May 1, 1990
[Anti-aggregants in 1990]M Verstraete
Acta Clinica Belgica|January 1, 1983
Thromboembolism in cancer patientsM Verstraete
La Revue Du Praticien|February 1, 1981
[Platelet antiaggregating agents]M Verstraete
Przeglad Lekarski|January 1, 1978
Antiplatelet agents in coronary disease: are they of prophylactic value?M Verstraete
Acta Clinica Belgica|January 1, 1981
The clinical relevance of hyperviscosityM Verstraete
Angiologica|January 1, 1970
Pseudo-intermittent claudicationM Verstraete
British Medical Journal|December 11, 1971
Streptokinase and myocardial infarctionM Verstraete
Panminerva Medica|April 1, 1973
The problem of new drugs in Europe. IntroductionM Verstraete
Drugs|January 1, 1991
Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseasesM Verstraete
British Journal of Clinical Pharmacology|January 1, 1983
Introduction: thromboxane in biological systems and the possible impact of its inhibitionM Verstraete
Pageof 42